Method for treating inflammatory conditions using an antibody to MIP-3&agr;
US6645491B1 · kind B1 · utility
6Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2000 |
| Grant date | Nov 11, 2003 |
| Priority date | — |
| Expiry date | Feb 2, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Agonists or antagonists of MIP-3&agr;, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the MIP-3&agr; chemokine is specifically capable of inducing migration of a skin cell subset.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.